AdolescentsHeadache Disorders (Cluster & Migraine)Chronic PainPsilocybinLSD

Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies

This review (s=9, 2022) analyses retrospective surveys that quantified the self-reported efficacy of two or more cluster headache (CH) treatments. The consistently reported efficacy of psilocybin and LSD in prophylactic treatment indicates the need for clinical studies in this area.

Authors

  • Emmanuelle Schindler

Published

Current Pain and Headache Reports
meta Study

Abstract

Purpose of Review: The use and efficacy of various substances in the treatment of CH have been studied in several retrospective surveys. The aim of the study is to systematically review published survey studies to evaluate the reported efficacies of both established and unconventional substances in the abortive and prophylactic treatment of both episodic and chronic CH, specifically assessing the consistency of the results.Recent Findings: No systematic review have been conducted of these studies previously. A systematic literature search with a set of search terms was conducted on PubMed. Retrospective surveys that quantified the self-reported efficacy of two or more CH treatments, published in English during 2000-2020, were included. Several key characteristics and results of the studies were extracted. A total of 994 articles were identified of which 9 were found to be eligible based on the selection criteria. In total, 5419 respondents were included. Oxygen and subcutaneous triptan injections were most reported as effective abortive treatments, while psilocybin and lysergic acid diethylamide were most commonly reported as effective prophylactic treatments. The reported efficacy of most substances was consistent across different studies, and there were marked differences in the reported efficacies of different substances. The reported order of efficacy is generally in agreement with clinical studies. The findings suggest that retrospective surveys can be used to obtain supporting information on the effects of various substances used in the treatment of CH and to form hypotheses about novel treatment methods. The consistently reported efficacy of psilocybin and LSD in prophylactic treatment indicates the need for clinical studies.

Available with Blossom Pro

Research Summary of 'Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies'

Introduction

Cluster headache (CH) is a severe trigeminal autonomic cephalalgia characterised by recurrent, unilateral attacks that can occur several times per day and in cluster cycles. The episodic form (ECH) is more common, while chronic CH (CCH) is defined by symptom persistence without remission for over a year. Conventional acute treatments recommended by guidelines include high-flow oxygen and subcutaneous or intranasal triptans; verapamil and lithium are commonly used preventives, with several other agents and neuromodulatory approaches used for refractory cases. At the same time, a substantial minority of patients report using complementary or unconventional pharmacological treatments, many of which lack formal clinical trial evidence. Retrospective patient surveys have been used to capture self-reported treatment effects, but their methodological heterogeneity has limited attempts to synthesise consistent patterns across studies. Santeri and colleagues set out to systematically review retrospective survey studies that quantify self-reported efficacy of two or more treatments for CH, published in English from 2000 to 2020. Their primary aims were to identify treatments consistently reported as most effective across surveys, assess consistency between surveys, and compare survey findings with randomized controlled trial (RCT) evidence. A secondary aim was to evaluate survey design features that could introduce bias into the reported outcomes.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

References (8)

Papers cited by this study that are also in Blossom

Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey

Schindler, E. A. D., Gottschalk, C. H., Weil, M. J. et al. · Journal of Psychoactive Drugs (2015)

91 cited
Increased use of illicit drugs in a Dutch cluster headache population

De Coo, I. F., Naber, W. C., Wilbrink, L. A. et al. · Cephalalgia (2018)

The pharmacology of psilocybin

Passie, T., Seifert, J., Schneider, U. et al. · Addiction Biology (2002)

The pharmacology of lysergic acid diethylamide: a review

Passie, T., Halpern, J. H., Stichtenoth, D. O. et al. · CNS Neuroscience and Therapeutics (2008)

82 cited
Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics

Schindler, E. A. D., Wallace, R. M., Sloshower, J. A. et al. · Frontiers in Pharmacology (2018)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.